Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
GI Stool Testing Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The gi stool testing market has demonstrated substantial growth in recent years. It is anticipated to increase from $1.41 billion in 2025 to $1.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion was fueled by factors including the rise in gastrointestinal disorders, progress in diagnostic laboratories, the implementation of early microbiology testing, an uptick in colorectal cancer screening, and improved healthcare awareness.
The gi stool testing market size is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $1.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is primarily driven by factors such as the increasing availability of personalized gut health testing, the rise of home diagnostics, the incorporation of AI-based analysis, the growing acceptance of preventive healthcare, and heightened awareness regarding digestive health. Key trends shaping the market during this period encompass an increasing preference for non-invasive diagnostic tools, a surge in the adoption of microbiome-based testing, greater utilization of molecular diagnostic techniques, the proliferation of home-based stool testing kits, and enhanced capabilities for the early detection of gastrointestinal disorders.
Get A Free Sample Report With In-Depth Market Insights:
GI Stool Testing Market Growth Catalysts And Demand Drivers
The growing occurrence of gastrointestinal conditions is anticipated to boost the GI stool testing market’s expansion in the future. These disorders encompass illnesses impacting the digestive tract, such as the stomach, intestines, and associated organs, leading to symptoms like nausea, diarrhea, constipation, and abdominal discomfort. The uptick in gastrointestinal ailments stems mainly from unhealthy eating patterns; consuming more processed foods, excessive sugar, and diets low in fiber upsets gut flora, diminishes digestive well-being, and fosters conditions like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is essential for gastrointestinal conditions to uncover infections, inflammation, or digestive system imbalances, as it aids in detecting pathogens (like bacteria, viruses, and parasites), indicators of gut inflammation, and deficiencies in digestive enzymes, thereby facilitating precise diagnosis and tailored treatment. An illustration of this trend is seen in September 2024, when the Centers for Disease Control and Prevention, a US government agency, disclosed that from 2024 to 2025, states involved in NoroSTAT documented 1,676 norovirus outbreaks, representing a notable increase from the 729 outbreaks noted in the corresponding period the previous season. Consequently, the expanding incidence of gastrointestinal disorders fuels the growth of the GI stool testing market.
GI Stool Testing Market Segmentation And Category Overview
The gi stool testing market covered in this report is segmented –
1) By Type: Immunoassay Test, Molecular Diagnostic Test, Chromatography-Based Test, Microbiological Culture Test, Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Sample Type: Fecal Samples, Serum Samples
3) By Equipment: Automated Analyzers, Benchtop Instruments, Portable Devices
4) By Application: Diagnosis Of Gastrointestinal Disorders, Screening For Colorectal Cancer, Monitoring Of Inflammatory Bowel Disease (IBD), Detection Of Gastrointestinal Infections, Evaluation Of Digestive Health
5) By End User: Hospital, Diagnostic Centre And Laboratory, Academic Institution, Research Centre Organization, Homecare, Other End Users
Subsegments:
1) By Immunoassay Test: Rapid Immunoassay, Lateral Flow Assay, Fluorescent Immunoassay
2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Test (NAAT), Next-Generation Sequencing (NGS)
3) By Chromatography-Based Test: Gas Chromatography (GC), Liquid Chromatography (LC), Thin-Layer Chromatography (TLC)
4) By Microbiological Culture Test: Aerobic Culture, Anaerobic Culture, Selective Media Culture
5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA
GI Stool Testing Market Industry Trends: What’s Reshaping Demand?
Leading companies in the GI stool testing market are prioritizing advanced testing technologies, such as comprehensive diagnostic tests, to enhance precision, speed, and early disease detection. A comprehensive diagnostic test serves as an advanced medical tool, evaluating multiple health parameters simultaneously to offer a thorough assessment of a patient’s condition. An illustration of this trend is seen in November 2024, when EmeritusDX, a US-based diagnostics company, introduced GI Detect. This comprehensive diagnostic test was developed to support healthcare providers in identifying gastrointestinal disorders, utilizing a single stool swab to detect 26 bacteria, viruses, and parasites linked to digestive system disruptions. With a 24-hour turnaround time, GI Detect enables swift and informed clinical decision-making. In addition to broad pathogen identification, the test also screens for Helicobacter pylori and its virulence factors VacA, cagA, and babA, as well as common gastrointestinal parasites like Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This extensive approach guarantees accurate and timely diagnosis of gastrointestinal infections.
GI Stool Testing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, ELITechGroup, Genova Diagnostics Inc., US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG, Qiagen NV, Roche Diagnostics, Siemens Healthineers, QuidelOrtho Corporation, Biohit Oyj, Exact Sciences Corporation
View The Full GI Stool Testing Market Report:
GI Stool Testing Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the GI stool testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









